Research ArticleArticle
In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
Vijay Bhasker Reddy
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Lakmal Boteju
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Asela Boteju
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Li Shen
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Kelem Kassahun
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Nageshwar Reddy
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Adrian Sheldon
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Sanjeev Luther
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Ke Hu
Rafael Pharmaceuticals, Cranbury, New Jersey (V.B.R., L.B., A.B., N.R., S.L., K.H.); Frontage Laboratories, Exton, Pennsylvania (L.S., K.K.); and Charles River Laboratories, Worcester, Massachusetts (A.S.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
β-Oxidation of CPI-613 in Rat and Human
Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
Drug Metabolism and Disposition April 1, 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
Research ArticleArticle
β-Oxidation of CPI-613 in Rat and Human
Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
Drug Metabolism and Disposition April 1, 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement